The pivotal FRAME (Fracture Study in Postmenopausal Women with Osteoporosis) trial evaluated the efficacy and safety of romosozumab in over 7,000 postmenopausal women (1). Over 12 months, romosozumab demonstrated a significant relative risk reduction in new vertebral fractures compared to placebo, alongside marked improvements in bone mineral densi
1294 Reached
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
Use of Clindamycin for Managing Bacterial Vaginosis
11172 Reached29 Comments8 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments